Your session is about to expire
← Back to Search
Intervention for Stomach Cancer
Study Summary
This trial will be testing the safety and effectiveness of the Indocyanine green dye (ICG) during surgery.
- Stomach Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 2 trial • 30 Patients • NCT01662752Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Do I fit the eligibility criteria to take part in this research?
"This clinical trial has a strict age limit of 18-75 and is only for patients with stomach cancer. They are looking to enroll 50 participants in total."
Could you please provide an overview of the risks associated with this treatment?
"The safety of this treatment was given a score of 3. This is due to the fact that this Phase 4 trial means that this treatment is already approved."
Can geriatric patients participate in this research?
"This trial is only for patients aged 18-75. If you are younger or older, there are 22 and 673 other trials you might be eligible for, respectively."
How may patients will be given this experimental medication?
"Right now, this clinical trial has no open positions. The trial was first posted on 1/1/2023 and was last updated on 2/15/2022. However, there are 648 other trials for cancer of the stomach that are actively recruiting patients and 32 for this particular treatment."
Share this study with friends
Copy Link
Messenger